Related Experiment Video
Updated: May 22, 2026
08:00
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Recent advances in cystic fibrosis
Jason Lobo1, Juan M Rojas-Balcazar, Peadar G Noone
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of North Carolina, Chapel Hill, 27599-7020, USA.
Clinics in Chest Medicine
|May 30, 2012
Summary
Cystic fibrosis (CF) is a genetic disorder impacting young patients. Advances in understanding CF genetics and pathophysiology have led to new treatments improving survival and quality of life.
Area of Science:
- Medical Genetics
- Pulmonology
- Clinical Medicine
Background:
- Cystic Fibrosis (CF) is a significant inherited chronic disease.
- It is a leading cause of morbidity and mortality, particularly in pediatric populations.
- Recent advancements have deepened our understanding of CF's genetic basis, pathophysiology, and clinical presentation.
Purpose of the Study:
- To review the current state of knowledge in CF genetics and pathophysiology.
- To highlight the impact of novel and developing treatments on patient outcomes.
- To emphasize the role of improved care delivery models in managing CF.
Main Methods:
- Literature review of recent advancements in CF research.
- Analysis of the impact of novel therapeutic strategies.
- Evaluation of quality improvement initiatives in CF care centers.
Main Results:
- Significant progress has been made in understanding CF genetics and disease mechanisms.
- Novel treatments are demonstrably improving quality of life and survival rates for CF patients.
- Team-based care and quality improvement projects enhance patient outcomes.
Conclusions:
- Continued research into CF genetics and pathophysiology is crucial.
- The development and implementation of targeted therapies are transforming CF care.
- Optimized, multidisciplinary care delivery is essential for maximizing patient outcomes in cystic fibrosis.
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...